Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Gastroenterology

Advertisement

Featured

News
08/06/2024
Findings of a new study support the role of fecal immunochemical testing in reducing mortality from colorectal cancer, researchers report.
Findings of a new study support the role of fecal immunochemical testing in reducing mortality from colorectal cancer, researchers report.
Findings of a new study support...
08/06/2024
Gastroenterology
FDA
News
07/30/2024
Shield is the first blood test cleared for primary colorectal cancer screening that meets Medicare performance requirements.
Shield is the first blood test cleared for primary colorectal cancer screening that meets Medicare performance requirements.
Shield is the first blood test...
07/30/2024
Gastroenterology
Bill Chey
Videos
07/30/2024
Dr Chey reviews his presentation on the role of diet in disorders of gut-brain interaction from Digestive Disease Week 2024.
Dr Chey reviews his presentation on the role of diet in disorders of gut-brain interaction from Digestive Disease Week 2024.
Dr Chey reviews his presentation...
07/30/2024
Gastroenterology
News
07/24/2024
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and...
07/24/2024
Gastroenterology
News
07/24/2024
C olorectal cancer, colon cancer, and noncardia gastric cancer were found to be associated with high consumption of ultraprocessed foods, according to recent research.
C olorectal cancer, colon cancer, and noncardia gastric cancer were found to be associated with high consumption of ultraprocessed foods, according to recent research.
C olorectal cancer, colon...
07/24/2024
Gastroenterology
FDA alert
FDA Alert
06/20/2024
The approval makes risankizumab the first IL-23 specific inhibitor approved for both moderate to severe ulcerative colitis and Crohn's disease.
The approval makes risankizumab the first IL-23 specific inhibitor approved for both moderate to severe ulcerative colitis and Crohn's disease.
The approval makes risankizumab...
06/20/2024
Advances in Inflammatory Bowel Disease Network
From Advances in Inflammatory Bowel Disease Network
Gut Check logo
Podcast
06/19/2024
In this episode of Gut Check, host Brian Lacy, MD, talks with Dr Ami Sperber about how disorders of gut-brain interaction can overlap, and how this can change treatment paradigms.
In this episode of Gut Check, host Brian Lacy, MD, talks with Dr Ami Sperber about how disorders of gut-brain interaction can overlap, and how this can change treatment paradigms.
In this episode of Gut Check,...
06/19/2024
Gastroenterology
FDA alert
FDA Alert
06/14/2024
The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.
The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.
The first-in-class PPAR is the...
06/14/2024
Gastroenterology
Video
06/14/2024
Kayla Monks, MS, RD, discusses nutritional needs and challenges of patients with liver disease, including candidates for transplant, and how to work with patients to achieve the best possible outcomes.
Kayla Monks, MS, RD, discusses nutritional needs and challenges of patients with liver disease, including candidates for transplant, and how to work with patients to achieve the best possible outcomes.
Kayla Monks, MS, RD, discusses...
06/14/2024
Gastroenterology
ALan Bonder
Podcast
06/05/2024
In this podcast, Drs Alan Bonder and Robert Gish discuss the need for universal screening for hepatitis D, the types of screening tests that should be used, and treatment options.
In this podcast, Drs Alan Bonder and Robert Gish discuss the need for universal screening for hepatitis D, the types of screening tests that should be used, and treatment options.
In this podcast, Drs Alan Bonder...
06/05/2024
Gastroenterology
Miguel Regueiro MD
Conference Coverage
06/03/2024
Dr Regueiro recaps the results from the pivotal study comparing the effects of risankizumab with ustekinumab on key biomarkers of inflammatory bowel disease, which he presented at Digestive Disease Week 2024.
Dr Regueiro recaps the results from the pivotal study comparing the effects of risankizumab with ustekinumab on key biomarkers of inflammatory bowel disease, which he presented at Digestive Disease Week 2024.
Dr Regueiro recaps the results...
06/03/2024
Advances in Inflammatory Bowel Disease Network
From Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

https://www.hmpgloballearningnetwork.com/site/ibd-app

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement